Question

Difficulty: MediumMenstrual Cycle Abnormalities and Contraception

Seeking evaluation for worsening fatigue and irregular vaginal bleeding, a 46-year-old woman presents to the gynecology clinic. For the past eight months, her menstrual cycles have become highly unpredictable, varying from 2121 to 4545 days in length. When she does menstruate, the bleeding lasts up to 1010 days and is extremely heavy, often requiring her to use two maxi pads simultaneously. Her previous cycles were regular, occurring every 2828 days. Her medical history includes type 2 diabetes mellitus, obesity, and hypothyroidism. Her current medications are metformin and levothyroxine. Vital signs include a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 135/85 mmHg135/85 \text{ mmHg}, and heart rate of 88/min88\text{/min}. Her BMI is 36 kg/m236 \text{ kg/m}^2. Pelvic examination demonstrates a normal-appearing cervix; the uterus is normal in size, mobile, and non-tender without palpable adnexal masses. A urine beta-hCG test is negative. Laboratory studies reveal a hemoglobin concentration of 10.1 g/dL10.1 \text{ g/dL}.

Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial biopsyAnswer
  2. B
    Immediate insertion of a levonorgestrel-releasing intrauterine device
  3. C
    Measurement of free thyroxine (T4) without thyroid-stimulating hormone (TSH)
  4. D
    Reassurance that these represent expected perimenopausal transitions
  5. E
    Measurement of serum total testosterone and dehydroepiandrosterone sulfate (DHEAS)

Answer

Endometrial biopsy
The correct answer is endometrial biopsy. This patient presents with abnormal uterine bleeding (AUB) characterized by heavy, prolonged, and irregular menses leading to anemia. In the evaluation of AUB in non-pregnant women, the patient's age and risk factors dictate the need for tissue sampling. Guidelines strongly recommend an endometrial biopsy as a first-line diagnostic test for all women aged 4545 years and older with AUB to evaluate for endometrial hyperplasia or endometrial carcinoma. Furthermore, this patient has additional significant risk factors for endometrial malignancy, including obesity and type 2 diabetes mellitus, which promote a state of chronic unopposed estrogen exposure due to peripheral aromatization of androgens.

Step-by-Step Solution

1
Identify the patient's primary presenting problem and demographics.
The patient is a 46-year-old woman presenting with abnormal uterine bleeding (AUB) and symptomatic anemia.
Age is the most critical branching point in the algorithm for evaluating abnormal uterine bleeding.
2
Assess for pregnancy and structural versus non-structural causes.
Pregnancy test is negative. Physical exam shows a normal-sized uterus, making obvious structural causes like large leiomyomas less likely.
Ruling out pregnancy is the mandatory first step for any premenopausal woman with AUB. A normal exam directs focus toward ovulatory dysfunction, endometrial processes, or coagulopathies (PALM-COEIN classification).
3
Apply clinical guidelines for endometrial evaluation based on age and risk factors.
The patient is over age 45, which is an absolute indication for endometrial tissue sampling. She also has obesity and diabetes, which are independent risk factors for endometrial cancer.
Patients aged 45 and older have a significantly increased risk of endometrial hyperplasia and carcinoma. Biopsy must be performed before initiating any medical therapy.

Key Concept

In women aged 45 years and older presenting with abnormal uterine bleeding, an endometrial biopsy is the mandatory first step to rule out endometrial hyperplasia or malignancy.
Estimated Time:1m 15s
Rate this question